Aclaris Therapeutics, Inc. (ACRS) › Total LiabilitiesAclaris Therapeutics, Inc. (ACRS) — Total LiabilitiesAnnual figures by fiscal year, from SEC filings.2014: $1.46M2015: $1.55M2016: $6.59M2017: $18.25M2018: $60.44M2019: $28.39M2020: $33.13M2021: $53.87M2022: $56.98M2023: $40.23M2024: $64.77M2025: $57.38M$57.38M2014Total Liabilities (USD)2025Fiscal YearTotal LiabilitiesChange YoY2025$57.38M-11.4%2024$64.77M+61.0%2023$40.23M-29.4%2022$56.98M+5.8%2021$53.87M+62.6%2020$33.13M+16.7%2019$28.39M-53.0%2018$60.44M+231.2%2017$18.25M+176.7%2016$6.59M+324.1%2015$1.55M+6.9%2014$1.46M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share